{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T20:05:00Z","timestamp":1789502700287,"version":"build-2803163510"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bone"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1016\/j.bone.2021.116105","type":"journal-article","created":{"date-parts":[[2021,7,8]],"date-time":"2021-07-08T07:17:09Z","timestamp":1625728629000},"page":"116105","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["The enteroendocrine-osseous axis in patients with long-term type 1 diabetes mellitus"],"prefix":"10.1016","volume":"153","author":[{"given":"Barbara","family":"Katra","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danuta","family":"Fedak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bart\u0142omiej","family":"Matejko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maciej T.","family":"Ma\u0142ecki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"W\u0119drychowicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bone.2021.116105_bb0005","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1002\/jbmr.321","article-title":"The osteoblast: an insulin target cell controlling glucose homeostasis","volume":"26","author":"Clemens","year":"2011","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2021.116105_bb0010","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/j.bone.2011.04.017","article-title":"Intermittent injections of osteocalcin improve glucose metabolism and prevent type 2 diabetes in mice","volume":"50","author":"Ferron","year":"2012","journal-title":"Bone"},{"key":"10.1016\/j.bone.2021.116105_bb0015","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.3945\/ajcn.2009.28151","article-title":"\u03b3-carboxylation of osteocalcin and insulin resistance in older men and women","volume":"90","author":"Shea","year":"2009","journal-title":"Am. J. Clin. Nutr."},{"key":"10.1016\/j.bone.2021.116105_bb0020","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1002\/dmrr.1045","article-title":"The uncarboxylated form of osteocalcin is associated with improved glucose intolerance and enhanced \u03b2-cell function in middle-aged male subjects","volume":"25","author":"Hwang","year":"2009","journal-title":"Diabetes Metab. Res. Rev."},{"key":"10.1016\/j.bone.2021.116105_bb0025","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/s00198-010-1184-7","article-title":"Serum undercarboxylated osteocalcin was inversely associated with plasma glucose level and fat mass in type 2 diabetes mellitus","volume":"22","author":"Kanazawa","year":"2011","journal-title":"Osteoporos. Int."},{"key":"10.1016\/j.bone.2021.116105_bb0030","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1055\/s-0034-1375666","article-title":"Associations between bone, fat tissue and metabolic control in children and adolescents with type 1 diabetes mellitus","volume":"122","author":"W\u0119drychowicz","year":"2014","journal-title":"Exp. Clin. Endocrinol. Diabetes"},{"key":"10.1016\/j.bone.2021.116105_bb0035","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.bone.2018.07.021","article-title":"Sclerostin and its association with insulin resistance in children and adolescents","volume":"120","author":"W\u0119drychowicz","year":"2019","journal-title":"Bone."},{"key":"10.1016\/j.bone.2021.116105_bb0040","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.bone.2018.08.007","article-title":"Sclerostin and its significance for children and adolescents with type 1 diabetes mellitus (T1D)","volume":"120","author":"W\u0119drychowicz","year":"2019","journal-title":"Bone."},{"key":"10.1016\/j.bone.2021.116105_bb0045","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.bone.2016.07.014","article-title":"Glucose-dependent insulinotropic polypeptide (GIP) dose-dependently reduces osteoclast differentiation and resorption","volume":"91","author":"Mabilleau","year":"2016","journal-title":"Bone."},{"key":"10.1016\/j.bone.2021.116105_bb0050","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.bone.2015.01.003","article-title":"Glucose-dependent insulinotropic polypeptide (GIP) directly affects collagen fibril diameter and collagen cross-linking in osteoblast cultures","volume":"74","author":"Mieczkowska","year":"2015","journal-title":"Bone."},{"key":"10.1016\/j.bone.2021.116105_bb0055","doi-asserted-by":"crossref","first-page":"170197","DOI":"10.1016\/j.peptides.2019.170197","article-title":"GIP and the gut-bone axis \u2013 physiological, pathophysiological and potential therapeutic implications","volume":"125","author":"Stensen","year":"2020","journal-title":"Peptides"},{"key":"10.1016\/j.bone.2021.116105_bb0060","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1007\/s11894-004-0087-1","article-title":"Metabolic bone disease and parenteral nutrition","volume":"6","author":"Hamilton","year":"2004","journal-title":"Curr. Gastroenterol. Rep."},{"key":"10.1016\/j.bone.2021.116105_bb0065","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.cell.2010.06.003","article-title":"Insulin signaling in osteoblasts integrates bone remodeling and energy metabolism","volume":"142","author":"Ferron","year":"2010","journal-title":"Cell."},{"key":"10.1016\/j.bone.2021.116105_bb0070","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1002\/jbmr.390","article-title":"GPRC6A mediates responses to osteocalcin in beta-cells in vitro and pancreas in vivo","volume":"26","author":"Pi","year":"2011","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2021.116105_bb0075","doi-asserted-by":"crossref","unstructured":"A. Mizokami, Y. Yasutake, J. Gao, M. Matsuda, I. Takahashi, H. Takeuchi, Osteocalcin induces release of glucagon-like peptide-1 and thereby stimulates insulin secretion in mice, PLoS ONE, 8 (2013) Article ID e57375. https:\/\/doi.org\/10.1371\/journal.pone.0057375.","DOI":"10.1371\/journal.pone.0057375"},{"key":"10.1016\/j.bone.2021.116105_bb0080","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1002\/dmrr.1045","article-title":"The uncarboxylated form of osteocalcin is associated with improved glucose intolerance and enhanced \u03b2-cell function in middle-aged male subjects","volume":"25","author":"Hwang","year":"2009","journal-title":"Diabetes Metab. Res. Rev."},{"key":"10.1016\/j.bone.2021.116105_bb0085","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1055\/s-0034-1368709","article-title":"Carboxylated and uncarboxylated forms of osteocalcin directly modulate the glucose transport system and inflammation in adipocytes","volume":"46","author":"Hill","year":"2014","journal-title":"Horm. Metab. Res."},{"key":"10.1016\/j.bone.2021.116105_bb0090","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1359\/jbmr.081234","article-title":"Plasma osteocalcin is inversely related to fat mass and plasma glucose in elderly Swedish men","volume":"24","author":"Kindbloom","year":"2009","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2021.116105_bb0095","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1016\/j.jdiacomp.2017.03.016","article-title":"Circulating osteocalcin is unrelated to glucose homoeostasis in adults with type 1 diabetes","volume":"31","author":"Yeap","year":"2017","journal-title":"J. Diabetes Complicat."},{"key":"10.1016\/j.bone.2021.116105_bb0100","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1210\/endo.141.3.7366","article-title":"Osteoblast-derived cells express functional glucose-dependent insulinotropic peptide receptors","volume":"141","author":"Bollag","year":"2000","journal-title":"Endocrinology"},{"key":"10.1016\/j.bone.2021.116105_bb0105","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/1472-6793-11-12","article-title":"Receptors and effects of gut hormones in three osteoblastic cell lines","volume":"11","author":"Pacheco-Pantoja","year":"2011","journal-title":"BMC Physiol."},{"key":"10.1016\/j.bone.2021.116105_bb0110","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1111\/bcp.12777","article-title":"Glucagon-like peptide-1 (GLP-1) receptor agonists: potential to reduce fracture risk in diabetic patients","volume":"81","author":"Luo","year":"2016","journal-title":"Br. I. Clin. Pharmacol."},{"key":"10.1016\/j.bone.2021.116105_bb0115","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1016\/j.bone.2007.01.007","article-title":"Glucose-dependent insulinotropic peptide-overexpressing transgenic mice have increased bone mass","volume":"40","author":"Xie","year":"2007","journal-title":"Bone"},{"key":"10.1016\/j.bone.2021.116105_bb0120","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1210\/jcem-60-1-120","article-title":"Immunoreactive gastric inhibitory polypeptide response to a meal during the first eighteen months after diagnosis of type 1 (insulin dependent.) diabetes mellitus","volume":"60","author":"Krarup","year":"1985","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.bone.2021.116105_bb0125","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1111\/j.0954-6820.1988.tb15895.x","article-title":"Gastric inhibitory polypeptide in newly diagnosed ketotic type I (insulin-dependent) diabetics","volume":"223","author":"Krarup","year":"1988","journal-title":"Acta Med. Scand."},{"key":"10.1016\/j.bone.2021.116105_bb0130","doi-asserted-by":"crossref","first-page":"647","DOI":"10.33549\/physiolres.931995","article-title":"Gut peptide hormones and pediatric type 1 diabetes mellitus","volume":"60","author":"Huml","year":"2011","journal-title":"Physiol. Res."},{"key":"10.1016\/j.bone.2021.116105_bb0135","doi-asserted-by":"crossref","first-page":"76","DOI":"10.2478\/folmed-2018-0056","article-title":"Serum levels of incretin hormones - GLP-1 and GIP in patients with type 1 diabetes mellitus","volume":"61","author":"Stanchev","year":"2019","journal-title":"Folia Med. (Plovdiv)."},{"key":"10.1016\/j.bone.2021.116105_bb0140","doi-asserted-by":"crossref","first-page":"2325","DOI":"10.1210\/jc.2014-2547","article-title":"Glucose-dependent insulinotropic polypeptide inhibits bone resorption in humans","volume":"99","author":"Nissen","year":"2014","journal-title":"JCEM Online"},{"key":"10.1016\/j.bone.2021.116105_bb0145","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1152\/ajpendo.00700.2009","article-title":"Inappropriate glucagon response after oral compared with isoglycemic intravenous glucose administration in pateints with type 1 diabetes","volume":"298","author":"Hare","year":"2010","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.bone.2021.116105_bb0150","first-page":"1312","article-title":"Incretin and bone","volume":"19","author":"Hamada","year":"2009","journal-title":"Clin. Calcium."},{"key":"10.1016\/j.bone.2021.116105_bb0155","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1530\/JOE-13-0146","article-title":"Optimal bone mechanical and material properties require a functional glucagon-like peptide-1 receptor","volume":"219","author":"Mabilleau","year":"2013","journal-title":"J. Endocrinol."},{"key":"10.1016\/j.bone.2021.116105_bb0160","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1530\/JOE-11-0015","article-title":"GLP-1 and exendin-4 can reverse hyperlipidic-related osteopenia","volume":"209","author":"Nuche-Berenguer","year":"2011","journal-title":"J. Endocrinol."},{"key":"10.1016\/j.bone.2021.116105_bb0165","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/j.stemcr.2016.02.002","article-title":"Activation of GLP-1 receptor promotes bone marrow stromal cell osteogenic differentiation through \u03b2-catenin","volume":"6","author":"Meng","year":"2016","journal-title":"Stem Cell Rep."},{"key":"10.1016\/j.bone.2021.116105_bb0170","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1002\/jbmr.1898","article-title":"Exendin-4, a glucagon-like peptide-1 receptor agonist, prevents osteopenia by promoting bone formation and suppressing bone resorption in aged ovariectomized rats","volume":"28","author":"Ma","year":"2013","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2021.116105_bb0175","doi-asserted-by":"crossref","first-page":"13651","DOI":"10.1038\/s41598-019-50117-z","article-title":"Glucagon-like peptide 1 and Glucagon-like peptide 2 in relation to osteoporosis in non-diabetic postmenopausal women","volume":"9","author":"Castillo","year":"2019","journal-title":"Sci Rep."},{"key":"10.1016\/j.bone.2021.116105_bb0180","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/j.bone.2009.07.008","article-title":"Four-month treatment with GLP-2 significantly increases hip BMD. A randomized, placebo-controlled, dose-ranging study in postmenopausal women with low BMD","volume":"45","author":"Henriksen","year":"2009","journal-title":"Bone"},{"key":"10.1016\/j.bone.2021.116105_bb0185","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.bone.2019.05.014","article-title":"GLP-2 and GIP exert separate effects on bone turnover: a randomized, placebo-controlled, crossover study in healthy young men","volume":"125","author":"Skov-Jeppesen","year":"2019","journal-title":"Bone."},{"key":"10.1016\/j.bone.2021.116105_bb0190","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1007\/s00125-018-4804-y","article-title":"Inappropriate glucagon and GLP-1 secretion in individuals with long-standing type 1 diabetes: effects of residual C-peptide","volume":"62","author":"Thivolet","year":"2019","journal-title":"Diabetologia."},{"key":"10.1016\/j.bone.2021.116105_bb0195","doi-asserted-by":"crossref","unstructured":"M.S.S. Hansen, M. Tencerova, J. Fr\u00f8lich, M. Kassem, M. Frost, Effects of gastric inhibitory polypeptide, glucagon-like peptide-1 and glucagon-like peptide-1 receptor agonists on bone cell metabolizm, Basic Clin. Pharmacol. Toxicol. 122 (2018) 25\u201337. doi: https:\/\/doi.org\/10.1111\/bcpt.12850. Epub 2017 Aug 11. PMID: 28722834 Review.","DOI":"10.1111\/bcpt.12850"}],"container-title":["Bone"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S8756328221002702?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S8756328221002702?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,9]],"date-time":"2025-11-09T03:46:00Z","timestamp":1762659960000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S8756328221002702"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":39,"alternative-id":["S8756328221002702"],"URL":"https:\/\/doi.org\/10.1016\/j.bone.2021.116105","relation":{},"ISSN":["8756-3282"],"issn-type":[{"value":"8756-3282","type":"print"}],"subject":[],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The enteroendocrine-osseous axis in patients with long-term type 1 diabetes mellitus","name":"articletitle","label":"Article Title"},{"value":"Bone","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bone.2021.116105","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"116105"}}